Printer Friendly

DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES RECORD FIRST QUARTER SALES

 COLUMBUS, Ohio, April 26 /PRNewswire/ -- Danninger Medical Technology, Inc. (NASDAQ: DANN) today announced earnings of $86,565, or $.02 per share, for the quarter ended March 31, 1993, compared to $155,311, or $.03 per share, for the same period a year ago.
 Net revenue for the first quarter advanced 23 percent to a record $2,607,812 from $2,115,132 for the same quarter in 1992. Both Danninger's Recovery Products Division (rehabilitation devices) and its wholly owned subsidiary, Cross Medical Products, Inc., "Cross" (spinal implants), experienced sales increases during the first quarter of 1993 versus last year.
 As a result of tc?ompany's conversion from the exclusive dealer program to open market sales, net sales benefited in the first quarter of 1993 while gross margin was lower. The continued commitment to research and development was evidenced by spending increases of 27 percent for the three months ended March 31, 1993 over the comparable period in 1992. Sales and marketing costs increased by 39 percent over 1992 levels primarily due to training for sales agents and surgeons by Cross.
 Danninger Medical Technology, Inc. designs, manufactures, and markets medical devices that assist patients in their recovery following surgery or trauma. Danninger is a leader in Continuous Passive Motion devices for the knee, hip, toe, wrist and hand. Cross Medical Products, Inc. specializes in developing and marketing orthopedic surgical instrumentation and spinal implants.
 DANNINGER MEDICAL TECHNOLOGY, INC.
 FINANCIAL HIGHLIGHTS
 Three Months Ended
 March 31,
 1993 1992
 Total Revenues $2,607,812 $2,115,132
 Net Income 86,565 155,311
 Net Income Per Share .02 .03
 Common Stock Equivalents 4,465,096 4,506,034
 March 31, December 31,
 1993 1992
 Total Assets $7,454,441 $7,667,400
 Working Capital 3,357,816 3,766,968
 Shareholders' Equity 3,821,200 3,727,160
 -0- 4/26/93
 /CONTACT: John Jenkins, chief financial officer, Danninger Medical Technology, Inc., 614-276-8267/
 (DANN)


CO: Danninger Medical Technology, Inc. ST: Ohio IN: MTC SU: ERN

BM -- CL017 -- 0683 04/26/93 12:31 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 26, 1993
Words:340
Previous Article:ROLLINS, INC. REPORTS RECORD FIRST QUARTER RESULTS; REVENUES UP 8 PERCENT AND EARNINGS UP 15 PERCENT
Next Article:LUBRIZOL DECLARES DIVIDEND
Topics:


Related Articles
IMEX MEDICAL SYSTEMS ANNOUNCES RECORD SALES FOR FIRST QUARTER
DANNINGER MEDICAL TECHNOLOGY, INC. THIRD QUARTER LOSS
SURVIVAL TECHNOLOGY, INC. ANNOUNCES 100 PERCENT EARNINGS INCREASE FOR FIRST QUARTER FISCAL 1993
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES IMPROVED SECOND QUARTER RESULTS
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES HIGHER THIRD QUARTER REVENUES AND IMPROVED RESULTS
DANNINGER MEDICAL TECHNOLOGY, INC. ANNOUNCES RECORD SALES FOR 1993; NET LOSS DUE TO PROVISIONS FOR CERTAIN INVENTORY AND ACCOUNTS RECEIVABLE
DANNINGER MEDICAL TECHNOLOGY, INC. REPORTS RECORD FIRST QUARTER SALES
BIRD MEDICAL TECHNOLOGIES REPORTS 1995 FIRST QUARTER INCOME
BIOMET ANNOUNCES FIRST QUARTER RESULTS
LIFEQUEST REPORTS FIRST QUARTER RESULTS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters